Steven Cakebread Sells 10,000 Shares of Yext Inc (NYSE:YEXT) Stock

Share on StockTwits

Yext Inc (NYSE:YEXT) CFO Steven Cakebread sold 10,000 shares of Yext stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $16.34, for a total value of $163,400.00.

Steven Cakebread also recently made the following trade(s):

  • On Tuesday, September 3rd, Steven Cakebread sold 10,000 shares of Yext stock. The shares were sold at an average price of $16.18, for a total value of $161,800.00.
  • On Monday, July 29th, Steven Cakebread sold 10,000 shares of Yext stock. The shares were sold at an average price of $21.25, for a total value of $212,500.00.
  • On Monday, August 5th, Steven Cakebread sold 10,000 shares of Yext stock. The shares were sold at an average price of $19.60, for a total value of $196,000.00.
  • On Monday, August 12th, Steven Cakebread sold 10,000 shares of Yext stock. The shares were sold at an average price of $20.37, for a total value of $203,700.00.
  • On Monday, August 19th, Steven Cakebread sold 10,000 shares of Yext stock. The shares were sold at an average price of $19.10, for a total value of $191,000.00.
  • On Monday, August 26th, Steven Cakebread sold 10,000 shares of Yext stock. The shares were sold at an average price of $18.22, for a total value of $182,200.00.
  • On Monday, July 22nd, Steven Cakebread sold 10,000 shares of Yext stock. The stock was sold at an average price of $20.52, for a total value of $205,200.00.
  • On Monday, July 15th, Steven Cakebread sold 10,000 shares of Yext stock. The stock was sold at an average price of $21.00, for a total value of $210,000.00.
  • On Monday, July 8th, Steven Cakebread sold 10,000 shares of Yext stock. The stock was sold at an average price of $20.23, for a total value of $202,300.00.
  • On Monday, July 1st, Steven Cakebread sold 10,000 shares of Yext stock. The stock was sold at an average price of $20.44, for a total value of $204,400.00.

NYSE:YEXT traded up $0.29 during midday trading on Thursday, hitting $17.60. 639,318 shares of the stock were exchanged, compared to its average volume of 908,980. Yext Inc has a one year low of $12.90 and a one year high of $26.18. The company has a market capitalization of $1.95 billion, a price-to-earnings ratio of -23.16 and a beta of 1.29. The business has a 50-day moving average price of $19.04 and a two-hundred day moving average price of $20.26. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.48.

Yext (NYSE:YEXT) last announced its earnings results on Thursday, August 29th. The company reported ($0.26) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.22) by ($0.04). The firm had revenue of $72.37 million for the quarter, compared to the consensus estimate of $71.86 million. Yext had a negative return on equity of 57.48% and a negative net margin of 33.57%. Yext’s revenue for the quarter was up 31.8% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.10) EPS. Sell-side analysts forecast that Yext Inc will post -0.99 EPS for the current fiscal year.

Several hedge funds and other institutional investors have recently bought and sold shares of YEXT. Geode Capital Management LLC grew its position in Yext by 3.6% during the 4th quarter. Geode Capital Management LLC now owns 992,825 shares of the company’s stock worth $14,743,000 after purchasing an additional 34,353 shares in the last quarter. BNP Paribas Arbitrage SA grew its position in Yext by 1,431.3% during the 1st quarter. BNP Paribas Arbitrage SA now owns 19,049 shares of the company’s stock worth $416,000 after purchasing an additional 17,805 shares in the last quarter. Quantamental Technologies LLC purchased a new position in Yext during the 1st quarter worth approximately $46,000. Janney Montgomery Scott LLC purchased a new position in Yext during the 1st quarter worth approximately $1,043,000. Finally, Rhumbline Advisers grew its position in Yext by 1.7% during the 1st quarter. Rhumbline Advisers now owns 110,704 shares of the company’s stock worth $2,420,000 after purchasing an additional 1,848 shares in the last quarter. 61.56% of the stock is currently owned by institutional investors.

Several equities research analysts recently commented on the company. Berenberg Bank set a $27.00 target price on Yext and gave the stock a “buy” rating in a report on Wednesday, September 4th. Zacks Investment Research cut Yext from a “buy” rating to a “hold” rating in a report on Saturday, August 3rd. SunTrust Banks set a $30.00 target price on Yext and gave the stock a “buy” rating in a report on Monday, August 26th. Finally, Oppenheimer set a $26.00 target price on Yext and gave the stock a “buy” rating in a report on Friday, August 30th. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. Yext has a consensus rating of “Buy” and an average target price of $24.33.

About Yext

Yext, Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and synchronize it to its knowledge network in North America and internationally. The company offers Yext Knowledge Engine, a cloud-based global platform that enables businesses to control and manage their digital knowledge and make it available through its knowledge Network of approximately 150 third-party maps, apps, search engines, intelligent GPS systems, digital assistants, vertical directories, and social networks.

Recommended Story: Stock Symbol

Insider Buying and Selling by Quarter for Yext (NYSE:YEXT)

Receive News & Ratings for Yext Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yext and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Scientific Games  Rating Lowered to Sell at ValuEngine
Scientific Games Rating Lowered to Sell at ValuEngine
Wingstop  Downgraded by BidaskClub
Wingstop Downgraded by BidaskClub
Encompass Health  Research Coverage Started at Deutsche Bank
Encompass Health Research Coverage Started at Deutsche Bank
Critical Contrast: PlusTherapeuticsInc   .  vs. Stryker
Critical Contrast: PlusTherapeuticsInc . vs. Stryker
Contrasting Sito Mobile  and Invictus Financial
Contrasting Sito Mobile and Invictus Financial
Pinnacle Financial Partners  Rating Reiterated by Stephens
Pinnacle Financial Partners Rating Reiterated by Stephens


 
© 2006-2019 Zolmax.